5:12 PM,
Jan. 17, 2014

Sameer Mungur is the founder and CEO of Zipscene, which secured $3.75 million of funding in the fourth quarter of 2013.

Written by

Cincinnati-area startups secured at least $83 million from the biggest U.S. venture capital deals in 2013, largely driven by new biotechnology companies that are gaining momentum here.

The Enquirer analyzed venture capital investments using the PwC/NVCA MoneyTree Report based on data from Thomson Reuters. The report breaks out venture capital deals by city every quarter. The list, however, is not comprehensive; angel, incubator and similar investments typically are not included.

Akebia Therapeutics, the Blue-Ash based biotechnology company, drove more than half of venture ...